Mycophenolic acid-treated dendritic cells generate regulatory CD4+ T cells that suppress CD8+ T cells' allocytotoxicity

International Immunology

Volumn 26, Issue 3, 2014, Pages 173-181

  Kazma, Ihab ^a   Lemoine, Roxane ^a   Herr, Florence ^a   Chadet, Stephanie ^a   Meley, Daniel ^a   Velge Roussel, Florence ^a   Lebranchu, Yvon ^a,b   Baron, Christophe ^a,b  

^a FHU SUPORT   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Cytotoxicity; Immune regulation; Organ transplantation

Indexed keywords

ANTIGEN INDUCED REGULATORY T LYMPHOCYTE; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANZYME A; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; MYCOPHENOLIC ACID; PERFORIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GRANZYME; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ALLOCYTOTOXICITY; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL DEGENERATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; ENZYME INHIBITION; GRAFT REJECTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY T LYMPHOCYTE; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; DRUG EFFECTS; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD4; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GRANZYMES; HUMANS; IMMUNOSUPPRESSION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MYCOPHENOLIC ACID; PERFORIN; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION IMMUNOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84895833556     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt054     Document Type: Article

References (43)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
2. Piccirillo, C. A. and Shevach, E. M. 2001. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol. 167:1137.
3. Strauss, L., Bergmann, C., Szczepanski, M., Gooding, W., Johnson, J. T. and Whiteside, T. L. 2007. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 13(15 Pt 1):4345.
4. Liyanage, U. K., Moore, T. T., Joo, H. G. et al. 2002. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169:2756.
5. Niedbala, W., Cai, B., Liu, H., Pitman, N., Chang, L. and Liew, F. Y. 2007. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc. Natl Acad. Sci. USA 104:15478.
6. Anderson, C. F., Oukka, M., Kuchroo, V. J. and Sacks, D. 2007. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204:285.
7. Sojka, D., Franta, Z., Horn, M. et al. 2008. Profiling of proteolytic enzymes in the gut of the tick Ixodes ricinus reveals an evolutionarily conserved network of aspartic and cysteine peptidases. Parasit. Vectors 1:7.
8. Chai, J. G., Tsang, J. Y., Lechler, R., Simpson, E., Dyson, J. and Scott, D. 2002. CD4+CD25+ T cells as immunoregulatory T cells in vitro. Eur. J. Immunol. 32:2365.
9. Takahashi, T., Kuniyasu, Y., Toda, M. et al. 1998. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.
10. Gao, Q., Rouse, T. M., Kazmerzak, K. and Field, E. H. 1999. CD4+CD25+ cells regulate CD8 cell anergy in neonatal tolerant mice. Transplantation 68:1891.
11. Fernandez, M. A., Puttur, F. K., Wang, Y. M., Howden, W., Alexander, S. I. and Jones, C. A. 2008. T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. 180:1556.
12. van Maurik, A., Herber, M., Wood, K. J. and Jones, N. D. 2002. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169:5401.
13. Graca, L., Thompson, S., Lin, C. Y., Adams, E., Cobbold, S. P. and Waldmann, H. 2002. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168:5558.
14. Lin, C. Y., Graca, L., Cobbold, S. P. and Waldmann, H. 2002. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat. Immunol. 3:1208.
15. Mempel, T. R., Pittet, M. J., Khazaie, K. et al. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25:129.
16. Dieckmann, D., Plottner, H., Berchtold, S., Berger, T. and Schuler, G. 2001. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193:1303.
17. Horwitz, D. A., Zheng, S. G. and Gray, J. D. 2008. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 29:429.
18. Curotto de Lafaille, M. A. and Lafaille, J. J. 2009. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30:626.
19. Lagaraine, C., Lemoine, R., Baron, C., Nivet, H., Velge-Roussel, F., and Lebranchu, Y. 2008. Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells. J. Leukoc. Biol 84:1057.
20. Lagaraine, C., Hoarau, C., Chabot, V., Velge-Roussel, F. and Lebranchu, Y. 2005. Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Int. Immunol. 17:351.
21. Lecoeur, H., Février, M., Garcia, S., Rivière, Y. and Gougeon, M. L. 2001. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253:177.
22. Peters, P. J., Borst, J., Oorschot, V. et al. 1991. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173:1099.
23. Trapani, J. A. and Smyth, M. J. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2:735.
24. Mittendorf, E. A., Storrer, C. E., Shriver, C. D., Ponniah, S. and Peoples, G. E. 2005. Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides. Breast Cancer Res. Treat. 92:85.
25. Betts, M. R., Brenchley, J. M., Price, D. A. et al. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65.
26. Piccirillo, C. A., Letterio, J. J., Thornton, A. M. et al. 2002. CD4(+) CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196:237.
27. Sakaguchi, S., Fukuma, K., Kuribayashi, K. and Masuda, T. 1985. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161:72.
28. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.
29. O'Shea, J. J., Ma, A. and Lipsky, P. 2002. Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37.
30. Câmara, N. O., Sebille, F. and Lechler, R. I. 2003. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur. J. Immunol. 33:3473.
31. Trzonkowski, P., Szmit, E., Myśliwska, J. and Myśliwski, A. 2006. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin. Immunol. 119:307.
32. Levings, M. K., Sangregorio, R. and Roncarolo, M. G. 2001. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295.
33. Takahashi, T., Tagami, T., Yamazaki, S. et al. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.
34. Kearley, J., Barker, J. E., Robinson, D. S. and Lloyd, C. M. 2005. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 202:1539.
35. Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A. M. and Adorini, L. 2001. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:1945.
36. Turnquist, H. R., Raimondi, G., Zahorchak, A. F., Fischer, R. T., Wang, Z. and Thomson, A. W. 2007. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J. Immunol. 178:7018.
37. Fujita, S., Sato, Y., Sato, K. et al. 2007. Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells. Blood 110:3793.
38. Taner, T., Hackstein, H., Wang, Z., Morelli, A. E. and Thomson, A. W. 2005. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 5:228.
39. Jiang, S., Camara, N., Lombardi, G. and Lechler, R. I. 2003. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 102:2180.
40. Hamdi, H., Godot, V., Maillot, M. C. et al. 2007. Induction of antigenspecific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 110:211.
41. Taylor, P. A., Lees, C. J. and Blazar, B. R. 2002. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493.
42. Yamagiwa, S., Gray, J. D., Hashimoto, S. and Horwitz, D. A. 2001. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J. Immunol. 166:7282.
43. Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D. and Salomon, B. L. 2002. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196:401.